Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
From Signaling Pathways to Combination Therapy: Bioactive Compounds against Cancer Stem Cells | Synapse
March 3, 2026
From Signaling Pathways to Combination Therapy: Bioactive Compounds against Cancer Stem Cells
PC
P. S. V. V. Charan
NP
Nikitha S. Pai
NN
Nivruthi A. Naik
Ver todo
Puntos clave
Combination therapy effectively targets cancer stem cells through synergistic bioactive compounds, showing promise in treatment.
The use of bioactive compounds in treatment strategies demonstrated enhanced effects in managing cancer stem cells over standard therapies.
Assessment focused on current knowledge of signaling pathways involved in cancer stem cells, offering insights for future research.
This approach highlights the potential for new treatment strategies, but further studies are necessary to validate effectiveness in clinical settings.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Charan et al. (Mon,) studied this question.
synapsesocial.com/papers/69a7658dbadf0bb9e87d9862
https://doi.org/https://doi.org/10.1007/s12015-026-11057-0